Michal Piksa, Magdalena Zaniewska, Agata Cieslik-Starkiewicz, Jonas Kunst, Mikolaj Morzy, Jan Piasecki, Rafal Rygula
{"title":"吸烟与易受错误信息影响之间的联系。","authors":"Michal Piksa, Magdalena Zaniewska, Agata Cieslik-Starkiewicz, Jonas Kunst, Mikolaj Morzy, Jan Piasecki, Rafal Rygula","doi":"10.1007/s00213-025-06802-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study investigates the relationship between tobacco smoking and susceptibility to misinformation, an area that has been underexplored despite its potential implications for public health and media literacy. Smoking behavior, along with the pharmacological components present in tobacco, is often associated with habitual and cognitive patterns that may influence an individual's ability to critically evaluate and discern false information. By examining this potential link, the present study aims to shed light on the broader implications of smoking for societal challenges, such as the spread of misinformation.</p><p><strong>Methods: </strong>A quantitative online survey was conducted to collect data from a sample of 1,575 adult participants (M<sub>age</sub> = 41.37, SD = 13.58; females: 54%, males: 46%) from the United Kingdom. Participants were categorized into three groups based on their smoking status: individuals who had smoked tobacco less than an hour before the study (n = 550), individuals who had smoked more than an hour before the study (n = 472), and non-smokers (n = 553). The survey incorporated questions assessing susceptibility to misinformation by annotating certain claims as false or true, and other instruments in order to control for impulsivity, stress level, physiological arousal and education level.</p><p><strong>Results: </strong>Smokers exhibited a lower ability to correctly recognize false claims than non-smokers. There was no difference between these groups in true news recognition.</p><p><strong>Discussion: </strong>The study, controlling for confounding factors, such as education and perceived stress, reveals that tobacco smoking may be associated with misinformation susceptibility. Further laboratory-based research should be conducted to explore the mechanisms underlying the observed relationship.</p>","PeriodicalId":20783,"journal":{"name":"Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The link between tobacco smoking and susceptibility to misinformation.\",\"authors\":\"Michal Piksa, Magdalena Zaniewska, Agata Cieslik-Starkiewicz, Jonas Kunst, Mikolaj Morzy, Jan Piasecki, Rafal Rygula\",\"doi\":\"10.1007/s00213-025-06802-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>This study investigates the relationship between tobacco smoking and susceptibility to misinformation, an area that has been underexplored despite its potential implications for public health and media literacy. Smoking behavior, along with the pharmacological components present in tobacco, is often associated with habitual and cognitive patterns that may influence an individual's ability to critically evaluate and discern false information. By examining this potential link, the present study aims to shed light on the broader implications of smoking for societal challenges, such as the spread of misinformation.</p><p><strong>Methods: </strong>A quantitative online survey was conducted to collect data from a sample of 1,575 adult participants (M<sub>age</sub> = 41.37, SD = 13.58; females: 54%, males: 46%) from the United Kingdom. Participants were categorized into three groups based on their smoking status: individuals who had smoked tobacco less than an hour before the study (n = 550), individuals who had smoked more than an hour before the study (n = 472), and non-smokers (n = 553). The survey incorporated questions assessing susceptibility to misinformation by annotating certain claims as false or true, and other instruments in order to control for impulsivity, stress level, physiological arousal and education level.</p><p><strong>Results: </strong>Smokers exhibited a lower ability to correctly recognize false claims than non-smokers. There was no difference between these groups in true news recognition.</p><p><strong>Discussion: </strong>The study, controlling for confounding factors, such as education and perceived stress, reveals that tobacco smoking may be associated with misinformation susceptibility. Further laboratory-based research should be conducted to explore the mechanisms underlying the observed relationship.</p>\",\"PeriodicalId\":20783,\"journal\":{\"name\":\"Psychopharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00213-025-06802-1\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00213-025-06802-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
The link between tobacco smoking and susceptibility to misinformation.
Introduction: This study investigates the relationship between tobacco smoking and susceptibility to misinformation, an area that has been underexplored despite its potential implications for public health and media literacy. Smoking behavior, along with the pharmacological components present in tobacco, is often associated with habitual and cognitive patterns that may influence an individual's ability to critically evaluate and discern false information. By examining this potential link, the present study aims to shed light on the broader implications of smoking for societal challenges, such as the spread of misinformation.
Methods: A quantitative online survey was conducted to collect data from a sample of 1,575 adult participants (Mage = 41.37, SD = 13.58; females: 54%, males: 46%) from the United Kingdom. Participants were categorized into three groups based on their smoking status: individuals who had smoked tobacco less than an hour before the study (n = 550), individuals who had smoked more than an hour before the study (n = 472), and non-smokers (n = 553). The survey incorporated questions assessing susceptibility to misinformation by annotating certain claims as false or true, and other instruments in order to control for impulsivity, stress level, physiological arousal and education level.
Results: Smokers exhibited a lower ability to correctly recognize false claims than non-smokers. There was no difference between these groups in true news recognition.
Discussion: The study, controlling for confounding factors, such as education and perceived stress, reveals that tobacco smoking may be associated with misinformation susceptibility. Further laboratory-based research should be conducted to explore the mechanisms underlying the observed relationship.
期刊介绍:
Official Journal of the European Behavioural Pharmacology Society (EBPS)
Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:
Human Psychopharmacology: Experimental
This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.
Human Psychopharmacology: Clinical and Translational
This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.
Preclinical psychopharmacology: Behavioral and Neural
This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.
Preclinical Psychopharmacology: Translational
This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.
Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic
This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.